Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advance Solid Tumors × iniparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Triple Negative Breast Neoplasms 4 Neoplasms 4 Breast Neoplasms 4 Recurrence 2 Ovarian Neoplasms 2 Hypersensitivity 2 Squamous Cell Lung Cancer 1 Solid Tumors 1 Neoplasm Metastasis 1 Glioblastoma 1 Fanconi Anemia, Complementation Group D1 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Advance Solid Tumors 1

Interventions

iniparib 1 Gemcitabine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01213381 2013-05-24

Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors

Sanofi

Phase 1 Completed

Other solid neoplasm

Advance Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡